Concord Wealth Partners Ark Genomic Revolution ETF (De Transaction History

Concord Wealth Partners

$603 Million
Q4 2024

Shares

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 04, 2022	BUY	$27.2 - $48.94 $380 - $685	14 Added 14.0%	114 $4,000
Q4 2020 Feb 16, 2021	BUY	$63.39 - $105.53 $6,339 - $10,553	100 New	100 $9,000

Others Institutions Holding ARKG

# of Institutions

281

Shares Held

25.4M

Call Options Held

3.02M

Put Options Held

2.65M

Goldman Sachs Group Inc New York, NY

3.63M
Shares

$97.9 Million
0.01% of portfolio
Jpmorgan Chase & CO New York, NY

2.96M
Shares

$79.8 Million
0.01% of portfolio
Bank Of America Corp Charlotte, NC

2.9M
Shares

$78.3 Million
0.01% of portfolio
Main Management ETF Advisors, LLC San Francisco, CA

2.43M
Shares

$65.6 Million
2.95% of portfolio
Citigroup Inc

1.68M
Shares

$45.4 Million
0.03% of portfolio

About ARK GENOMIC REVOLUTION ETF (DE

Ticker ARKG
Sector ETFs
Industry ETFs

More about ARKG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Concord Wealth Partners with notifications on news.